{"original_text": "**INSTITUTION\nTransfer Summary\nName :\n**NAME[AAA , BBB]\nAcct # :\n**ID-NUM\nMRN :\n**ID-NUM\nAdmitted :\n**DATE[Apr 23 2007]\nDischarged :\n**DATE[Apr 29 2007]\nDict :\n**NAME[XXX , WWW]\nAttend :\n**NAME[ZZZ , YYY]\nPRIMARY DISCHARGE DIAGNOSES :\n1. Pulmonary fibrosis secondary to interferon use .\n2. Pneumonia .\n3. Lethargy .\n4. Hepatitis C .\n5. Chronic pain .\nSECONDARY DISCHARGE DIAGNOSES :\n1. Hypothyroidism .\n2. Diabetes mellitus .\n3. History of recurrent ascites .\n4. History of portal hypertension secondary to hepatitis C .\n5. History of Clostridium difficile colitis .\nTRANSFER CONDITION :\nStable .\nPROCEDURES :\n1. On **DATE[Apr 24 2007] , chest x-ray showed bilateral pulmonary fibrosis , unchanged , no acute cardiopulmonary change .\n2. On **DATE[Apr 22 2007] , chest x-ray showed diffuse bilaterally pulmonary infiltrates or edema , unchanged .\n3. On **DATE[Apr 21 2007] , chest x-ray showed bilateral interstitial fibrosis , superimposed bilateral pneumonia cannot be excluded .\nCONSULTS :\nDr. **NAME[VVV UUU] ( GI ) .\nREASON FOR ADMISSION :\nMs. **NAME[AAA] is a **AGE[in 40s]- year - old female with a history of hepatitis C and pulmonary fibrosis secondary to interferon treatment who is transferred from **INSTITUTION with a chief complaint of shortness of breath .\n**INSTITUTION COURSE :\nMs. **NAME[AAA] is a **AGE[in 40s]- year - old female with a history of hepatitis C and pulmonary fibrosis secondary to interferon treatment who was admitted from **INSTITUTION with a chief complaint of shortness of breath .\nDuring her admission to the outside hospital , she was noted to have pneumonia and was started on IV Zosyn and IV vancomycin for this .\nIn addition , she was noted to be lethargic .\nFor her pneumonia , we maintained her on her IV Zosyn and IV vancomycin .\nShe remained afebrile during her stay here .\nHe blood cultures showed no growth .\nShe was initially on 4 to 10 liters of oxygen by Oxymizer .\nHowever , on the day of transfer , she was weaned down to 2 L of O2 by nasal cannula .\nA sputum culture was ordered but was not able to be obtained .\nFor her pulmonary fibrosis , she was maintained on oxygen .\nThe patient noticed a slight improvement in her shortness of breath by the time of transfer .\nShe was started on albuterol , Atrovent , Imuran , and Pulmicort .\nHer lethargy was thought to be secondary to narcotic overdose at the outside hospital .\nWhile there , she received IV Dilaudid .\nUpon admission to **INSTITUTION , we stopped her Dilaudid and gradually decreased her OxyContin .\nBy the time of discharge , she was taking 30 mg of OxyContin by mouth every 12 hours with 5 mg of oxycodone p.o. q.4 h. p.r.n. breakthrough pain .\nFollowing a decrease of her pain medications as well as her Ativan , her mental status greatly improved .\nOn the day of transfer , she was sitting up in bed and was able to walk around the hallways .\nShe was also seen by Dr. **NAME[UUU] ( GI ) for her hepatitis and history of ascites .\nWe obtained ammonia levels which were slightly elevated ( from 51.9 to 97.2 ) .\nHer decreased level of consciousness was not thought to be secondary to hepatic encephalopathy .\nShe was maintained on a low-protein diet .\nShe was also started on Aldactone , Lasix , lactulose , and Neomycin .\nHer Aldactone was stopped by GI on the day of transfer .\nAt the time of transfer , the patient reports that she is still having occasional diarrhea .\nFor prophylaxis , she was started on SCD s as well as Protonix .\nShe was followed by physical therapy and occupational therapy .\nFor her pain , she was continued on OxyContin and oxycodone .\nTRANSFER MEDICATIONS :\n1. Prozac 60 mg p.o. q.a.m.\n2. Oxycodone 5 mg p.o. q.3 h. p.r.n. pain .\n3. DuoNeb 3 mL inhalation solution b.i.d.\n4. OxyContin 30 mg p.o. q.12 h .\n5. Lorazepam 1 mg p.o. nightly .\n6. Vancomycin 1 g IV q.24 h .\n7. Imuran 50 mg p.o. b.i.d.\n8. Pulmicort 0.25 mg aerosolized b.i.d.\n9. Neomycin 1000 mg p.o. q.6 h .\n10. Folic acid 1 mg p.o. daily .\n11. Lasix 40 mg p.o. daily .\n12. Synthroid 150 mcg p.o. daily .\n13. Nadolol 40 mg p.o. daily .\n14. Protonix 40 mg p.o. daily .\n15. Zosyn 4.5 g IV q.8 h .\n16. Lactulose 20 g p.o. q.i.d.\n17. Albuterol 0.5 mL aerosolized q.4 h. p.r.n.\n18. Atrovent 3 mL aerosolized q.4 h. p.r.n.\nTRANSFER ORDERS :\nTransfer orders are as per the order form .\nThe patient is to continue her IV antibiotics ( vancomycin and Zosyn ) for 7 additional days .\nShe is to follow up with Dr. **NAME[ZZZ] in one week .\nDiet is low protein .\nActivity is as tolerated .\nPhysical therapy and occupational therapy should continue to work with Ms. **NAME[AAA] .\nMs. **NAME[AAA] is to call her physician or return to the hospital should she have further shortness of breath , fever , chills , or abdominal distention .\n______________________________\n**NAME[WWW XXX]\nHS Job # 135136 / 33115 /\nSHY # **ID-NUM\nD :\n**DATE[Apr 29 2007] 15:43\nT :\n**DATE[Apr 29 2007] 16:43\n**CARBON-COPY\n", "marked_up_text": "**INSTITUTION\nTransfer Summary\nName :\n**NAME[AAA , BBB]\nAcct # :\n**ID-NUM\nMRN :\n**ID-NUM\nAdmitted :\n**DATE[Apr 23 2007]\nDischarged :\n**DATE[Apr 29 2007]\nDict :\n**NAME[XXX , WWW]\nAttend :\n**NAME[ZZZ , YYY]\n[PRIMARY](261424001) DISCHARGE DIAGNOSES :\n[1. Pulmonary fibrosis](51615001) secondary to interferon use .\n2. [Pneumonia](233604007) .\n3. [Lethargy](214264003) .\n4. [Hepatitis C](50711007&707341005&40468003&66071002&7111000119109&397575003) .\n5. [Chronic pain](82423001) .\nSECONDARY DISCHARGE DIAGNOSES :\n[1. Hypothyroidism](40930008) .\n[2. Diabetes mellitus](73211009) .\n3. [History](392521001) of recurrent [ascites](389026000) .\n[4. History of portal hypertension](59701000119109) secondary to [hepatitis C](50711007&707341005&40468003&66071002&7111000119109&397575003) .\n5. [History](392521001) of [Clostridium difficile colitis](423590009) .\nTRANSFER CONDITION :\nStable .\n[PROCEDURES](71388002) :\n1. On **DATE[Apr 24 2007] , [chest x-ray](399208008) showed bilateral [pulmonary fibrosis](51615001) , [unchanged](260388006) , no acute cardiopulmonary change .\n2. On **DATE[Apr 22 2007] , [chest x-ray](399208008) showed diffuse bilaterally [pulmonary infiltrates](409609008) or [edema](267038008&79654002) , [unchanged](260388006) .\n3. On **DATE[Apr 21 2007] , [chest x-ray](399208008) showed bilateral [interstitial fibrosis](125565008) , superimposed [bilateral pneumonia](407671000) cannot be excluded .\nCONSULTS :\nDr. **NAME[VVV UUU] ( GI ) .\nREASON FOR ADMISSION :\nMs. **NAME[AAA] is a **AGE[in 40s]- year - old female with a [history of hepatitis C](93871000119101&429721005&428030001) [and pulmonary fibrosis](51615001) secondary to interferon treatment who is transferred from **INSTITUTION with a [chief complaint](33962009) of [shortness of breath](267036007) .\n**INSTITUTION COURSE :\nMs. **NAME[AAA] is a **AGE[in 40s]- year - old female with a [history of hepatitis C](93871000119101&429721005&428030001) [and pulmonary fibrosis](51615001) secondary to interferon treatment who was admitted from **INSTITUTION with a [chief complaint](33962009) of [shortness of breath](267036007) .\nDuring her admission to the outside hospital , she was noted to have [pneumonia](233604007) and was started on IV Zosyn and IV vancomycin for this .\nIn addition , she was noted to be [lethargic](214264003) .\nFor her [pneumonia](233604007) , we maintained her on her IV Zosyn and IV vancomycin .\nShe remained [afebrile](86699002&386661006) during her stay here .\nHe [blood cultures](30088009) showed no growth .\nShe was initially on 4 to 10 liters of [oxygen](24099007) by Oxymizer .\nHowever , on the day of transfer , she was weaned down to 2 L of O2 by [nasal](738948007) cannula .\nA sputum [culture](703725008&61594008) was ordered but was not [able](371150009) to be obtained .\nFor her [pulmonary fibrosis](51615001) , she was maintained on [oxygen](24099007) .\nThe patient noticed a slight improvement in her [shortness of breath](267036007) by the time of transfer .\nShe was started on [albuterol](372897005&91143003) , Atrovent , Imuran , and Pulmicort .\nHer [lethargy](214264003) was thought to be secondary to [narcotic overdose](242253008) at the outside hospital .\nWhile there , she received IV Dilaudid .\nUpon admission to **INSTITUTION , we stopped her Dilaudid and gradually decreased her OxyContin .\nBy the time of discharge , she was taking 30 mg of OxyContin by mouth every 12 hours with 5 mg of [oxycodone](55452001&414984009) p.o. q.4 h. p.r.n. breakthrough [pain](22253000) .\nFollowing a decrease of her [pain](22253000) medications as well as her Ativan , her [mental status](36456004) greatly [improved](385425000) .\nOn the day of transfer , she was [sitting](33586001) up in bed and was [able to walk](282144007&282145008) around the hallways .\nShe was also seen by Dr. **NAME[UUU] ( GI ) for her [hepatitis](128241005) and [history](392521001) of [ascites](389026000) .\nWe obtained [ammonia levels](59960001) which were slightly elevated ( from 51.9 to 97.2 ) .\nHer [decreased level of consciousness](443371007&417473004) was not thought to be secondary to [hepatic encephalopathy](13920009) .\nShe was maintained on a low-[protein diet](76713001) .\nShe was also started on Aldactone , Lasix , [lactulose](273945008&111137007) , and Neomycin .\nHer Aldactone was stopped by GI on the day of transfer .\nAt the time of transfer , the patient reports that she is still having occasional [diarrhea](62315008) .\nFor [prophylaxis](169443000&360271000) , she was started on SCD s as well as Protonix .\nShe was followed by physical [therapy](276239002&277132007) [and occupational therapy](84478008) .\nFor her [pain](22253000) , she was continued on OxyContin and [oxycodone](55452001&414984009) .\nTRANSFER MEDICATIONS :\n1. Prozac 60 mg p.o. q.a.m.\n2. [Oxycodone](55452001&414984009) 5 mg p.o. q.3 h. p.r.n. [pain](22253000) .\n3. DuoNeb 3 mL inhalation solution b.i.d.\n4. OxyContin 30 mg p.o. q.12 h .\n5. [Lorazepam](387106007&19225000) 1 mg p.o. nightly .\n6. Vancomycin 1 g IV q.24 h .\n7. Imuran 50 mg p.o. b.i.d.\n8. Pulmicort 0.25 mg aerosolized b.i.d.\n9. Neomycin 1000 mg p.o. q.6 h .\n10. [Folic acid 1](63718003&6247001) mg p.o. daily .\n11. Lasix 40 mg p.o. daily .\n12. Synthroid 150 mcg p.o. daily .\n13. [Nadolol](387482003&82896009) 40 mg p.o. daily .\n14. Protonix 40 mg p.o. daily .\n15. Zosyn 4.5 g IV q.8 h .\n16. [Lactulose](273945008&111137007) 20 g p.o. q.i.d.\n17. [Albuterol](372897005&91143003) 0.5 mL aerosolized q.4 h. p.r.n.\n18. Atrovent 3 mL aerosolized q.4 h. p.r.n.\nTRANSFER ORDERS :\nTransfer orders are as per the order form .\nThe patient is to continue her IV antibiotics ( vancomycin and Zosyn ) for 7 additional days .\nShe is to follow up with Dr. **NAME[ZZZ] in one week .\nDiet is low protein .\nActivity is as tolerated .\nPhysical [therapy](276239002&277132007) [and occupational therapy](84478008) should continue to work with Ms. **NAME[AAA] .\nMs. **NAME[AAA] is to call her physician or return to the hospital should she have further [shortness of breath](267036007) , [fever](386661006) , [chills](43724002) , [or abdominal distention](60728008) .\n______________________________\n**NAME[WWW XXX]\nHS Job # 135136 / 33115 /\n[SHY](224952000) # **ID-NUM\nD :\n**DATE[Apr 29 2007] 15:43\nT :\n**DATE[Apr 29 2007] 16:43\n**[CARBON](87453002)-COPY\n", "filename": "0203.txt", "disorders": [{"code": "125565008", "name": "Interstitial fibrosis", "count": 1}, {"code": "128241005", "name": "Inflammatory disease of liver", "count": 1}, {"code": "13920009", "name": "Hepatic encephalopathy", "count": 1}, {"code": "233604007", "name": "Pneumonia", "count": 3}, {"code": "242253008", "name": "Overdose of opiate", "count": 1}, {"code": "389026000", "name": "Ascites", "count": 2}, {"code": "397575003", "name": "Viral hepatitis, type G", "count": 2}, {"code": "40468003", "name": "Hepatitis A", "count": 2}, {"code": "407671000", "name": "Bilateral pneumonia", "count": 1}, {"code": "40930008", "name": "Hypothyroidism", "count": 1}, {"code": "423590009", "name": "Clostridium difficile colitis", "count": 1}, {"code": "50711007", "name": "Hepatitis C", "count": 2}, {"code": "51615001", "name": "Pulmonary fibrosis", "count": 5}, {"code": "66071002", "name": "Hepatitis B", "count": 2}, {"code": "707341005", "name": "Viral hepatitis D", "count": 2}, {"code": "7111000119109", "name": "Viral hepatitis E", "count": 2}, {"code": "73211009", "name": "Diabetes mellitus", "count": 1}], "symptoms": [{"code": "214264003", "name": "Lethargy", "count": 3}, {"code": "22253000", "name": "Pain", "count": 4}, {"code": "224952000", "name": "Introvert", "count": 1}, {"code": "260388006", "name": "No change", "count": 2}, {"code": "267036007", "name": "Dyspnoea", "count": 4}, {"code": "267038008", "name": "Oedema", "count": 1}, {"code": "282144007", "name": "Able to walk", "count": 1}, {"code": "282145008", "name": "Unable to walk", "count": 1}, {"code": "33586001", "name": "Sitting position", "count": 1}, {"code": "33962009", "name": "Chief complaint", "count": 2}, {"code": "36456004", "name": "Mental state finding", "count": 1}, {"code": "371150009", "name": "Able", "count": 1}, {"code": "385425000", "name": "Improved", "count": 1}, {"code": "386661006", "name": "Fever", "count": 2}, {"code": "392521001", "name": "History of", "count": 3}, {"code": "409609008", "name": "Radiologic infiltrate of lung", "count": 1}, {"code": "417473004", "name": "O/E - decreased level of consciousness", "count": 1}, {"code": "428030001", "name": "History of hepatitis A", "count": 2}, {"code": "429721005", "name": "History of hepatitis B", "count": 2}, {"code": "43724002", "name": "Chill", "count": 1}, {"code": "443371007", "name": "Decreased level of consciousness", "count": 1}, {"code": "59701000119109", "name": "History of portal hypertension", "count": 1}, {"code": "60728008", "name": "Abdominal swelling", "count": 1}, {"code": "62315008", "name": "Diarrhoea", "count": 1}, {"code": "738948007", "name": "Nasal", "count": 1}, {"code": "79654002", "name": "Oedema", "count": 1}, {"code": "82423001", "name": "Chronic pain", "count": 1}, {"code": "86699002", "name": "Apyrexial", "count": 1}, {"code": "93871000119101", "name": "History of hepatitis C", "count": 2}], "treatments": [{"code": "111137007", "name": "Lactulose-containing product", "count": 2}, {"code": "169443000", "name": "Preventive procedure", "count": 1}, {"code": "19225000", "name": "Lorazepam-containing product", "count": 1}, {"code": "24099007", "name": "Oxygen", "count": 2}, {"code": "261424001", "name": "Primary operation", "count": 1}, {"code": "273945008", "name": "Lactulose", "count": 2}, {"code": "276239002", "name": "Therapy", "count": 2}, {"code": "277132007", "name": "Therapeutic procedure", "count": 2}, {"code": "360271000", "name": "Prophylaxis - intent", "count": 1}, {"code": "372897005", "name": "Salbutamol", "count": 2}, {"code": "387106007", "name": "Lorazepam", "count": 1}, {"code": "387482003", "name": "Nadolol", "count": 1}, {"code": "414984009", "name": "Oxycodone-containing product", "count": 3}, {"code": "55452001", "name": "Oxycodone", "count": 3}, {"code": "6247001", "name": "Folic acid-containing product", "count": 1}, {"code": "63718003", "name": "Folic acid", "count": 1}, {"code": "71388002", "name": "Procedure", "count": 1}, {"code": "76713001", "name": "Protein diet", "count": 1}, {"code": "82896009", "name": "Nadolol-containing product", "count": 1}, {"code": "84478008", "name": "Occupational therapy", "count": 2}, {"code": "87453002", "name": "Carbon", "count": 1}, {"code": "91143003", "name": "Salbutamol-containing product", "count": 2}], "tests": [{"code": "30088009", "name": "Blood culture", "count": 1}, {"code": "399208008", "name": "Plain chest X-ray", "count": 3}, {"code": "59960001", "name": "Ammonia measurement", "count": 1}, {"code": "61594008", "name": "Microbial culture", "count": 1}, {"code": "703725008", "name": "Culture", "count": 1}]}
